中国医药
(600056)
| 流通市值：130.39亿 | | | 总市值：130.44亿 |
| 流通股本：14.95亿 | | | 总股本：14.96亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,340,674,174.04 | 3,323,205,946.05 | 2,409,805,111.08 | 4,088,893,984.89 |
| 交易性金融资产 | 2,944,079.86 | 122,283,434.58 | 122,283,434.58 | 122,283,434.58 |
| 衍生金融资产 | 73,605.31 | - | - | - |
| 应收票据及应收账款 | 15,892,319,768.45 | 16,017,357,224.8 | 15,862,965,352.32 | 14,345,809,500.02 |
| 其中：应收票据 | 202,861,875.63 | 208,446,139.03 | 201,189,134.26 | 163,190,145.75 |
| 应收账款 | 15,689,457,892.82 | 15,808,911,085.77 | 15,661,776,218.06 | 14,182,619,354.27 |
| 应收款项融资 | 873,647,090.93 | 818,706,570.02 | 622,108,555.83 | 564,180,101.58 |
| 预付款项 | 784,554,649.57 | 828,798,786.41 | 1,053,612,340.47 | 789,458,472.3 |
| 其他应收款合计 | 1,822,565,736.16 | 1,826,421,485.68 | 1,714,681,738.48 | 1,818,350,443.63 |
| 存货 | 6,158,471,952.61 | 6,152,066,196.86 | 6,196,065,259.14 | 6,072,507,057.85 |
| 合同资产 | 244,347,974.27 | 202,793,727.75 | 41,600,245.42 | 42,763,856.89 |
| 一年内到期的非流动资产 | - | 3,247,544.17 | 3,463,667.17 | 3,192,911.18 |
| 其他流动资产 | 249,479,003.99 | 296,533,527.8 | 253,283,856.19 | 231,621,759.84 |
| 流动资产合计 | 29,369,078,035.19 | 29,591,414,444.12 | 28,279,869,560.68 | 28,079,061,522.76 |
| 非流动资产: | | | | |
| 长期应收款 | 6,655,631.36 | 3,336,786.19 | 8,201,460.31 | 8,116,708.7 |
| 长期股权投资 | 2,726,877,719.27 | 2,714,877,719.27 | 2,695,845,129.5 | 2,687,623,629.5 |
| 其他权益工具投资 | 42,878,842.51 | 42,878,842.51 | 42,878,842.51 | 46,998,005.22 |
| 投资性房地产 | 87,545,508.43 | 88,596,212.71 | 89,681,416.99 | 88,608,056.98 |
| 固定资产 | 2,282,353,077.16 | 2,225,207,950.52 | 2,223,554,559.51 | 2,279,728,619.4 |
| 在建工程 | 222,320,765.58 | 308,848,055.2 | 285,767,384.47 | 280,225,098.23 |
| 使用权资产 | 332,346,689.82 | 343,030,079.81 | 334,017,739.61 | 195,703,619.36 |
| 无形资产 | 1,046,082,587.27 | 1,054,552,429.19 | 782,878,735.38 | 768,586,431.46 |
| 开发支出 | 448,755,600.67 | 444,737,450.29 | 451,217,827.75 | 473,533,430.92 |
| 商誉 | 1,041,804,092.12 | 1,041,804,092.12 | 878,276,253.25 | 878,276,253.25 |
| 长期待摊费用 | 166,855,729.88 | 162,760,676.83 | 145,295,673.41 | 145,113,887.44 |
| 递延所得税资产 | 700,033,024.64 | 704,041,800.09 | 683,546,388.17 | 681,483,203.27 |
| 其他非流动资产 | 234,946,475.19 | 218,546,664.57 | 576,226,560.75 | 257,911,341.28 |
| 非流动资产合计 | 9,339,455,743.9 | 9,353,218,759.3 | 9,197,387,971.61 | 8,791,908,285.01 |
| 资产总计 | 38,708,533,779.09 | 38,944,633,203.42 | 37,477,257,532.29 | 36,870,969,807.77 |
| 流动负债: | | | | |
| 短期借款 | 4,572,737,380.47 | 4,451,894,722.17 | 4,343,733,256.98 | 3,979,252,760.88 |
| 应付票据及应付账款 | 10,743,872,955.83 | 10,589,897,415.62 | 10,655,098,955.72 | 10,338,050,451.2 |
| 其中：应付票据 | 2,227,084,656.31 | 1,963,533,369.34 | 2,166,783,220.85 | 2,145,698,955.95 |
| 应付账款 | 8,516,788,299.52 | 8,626,364,046.28 | 8,488,315,734.87 | 8,192,351,495.25 |
| 预收款项 | 1,653,731.84 | 1,166,313.81 | 1,450,382.26 | 1,085,005.45 |
| 合同负债 | 1,148,246,763.14 | 1,195,636,714.35 | 1,095,618,312.14 | 1,166,723,572.17 |
| 应付职工薪酬 | 212,072,408.3 | 156,072,267.83 | 171,289,543.96 | 283,549,956.02 |
| 应交税费 | 161,638,422.26 | 231,285,579.19 | 217,093,400.1 | 257,707,206.08 |
| 其他应付款合计 | 2,157,662,193.71 | 2,179,379,472.16 | 2,046,077,468.46 | 1,997,454,170.58 |
| 应付股利 | 2,570,897.91 | 51,404,335.1 | 2,531,145.59 | 2,531,145.59 |
| 一年内到期的非流动负债 | 369,680,284.22 | 424,071,422.26 | 149,352,950.57 | 462,247,827 |
| 其他流动负债 | 1,163,643,336.04 | 1,217,562,094.78 | 1,194,214,944.15 | 1,239,443,014.32 |
| 流动负债合计 | 20,531,207,475.81 | 20,446,966,002.17 | 19,873,929,214.34 | 19,725,513,963.7 |
| 非流动负债: | | | | |
| 长期借款 | 324,300,000 | 672,850,000 | 770,550,000 | 670,750,000 |
| 应付债券 | 998,717,174.77 | 998,600,880.47 | - | - |
| 租赁负债 | 289,806,127.05 | 290,322,125.66 | 272,974,653.5 | 147,301,144.54 |
| 长期应付款 | 1,862,478,601.1 | 1,873,887,401.07 | 1,876,074,101.07 | 1,881,040,951.47 |
| 长期应付职工薪酬 | 13,866,763.42 | 14,267,546.7 | 14,661,947.73 | 15,181,022.67 |
| 预计负债 | 7,114,231.69 | 3,055,228.48 | 1,686,000.26 | 1,705,750.26 |
| 递延收益 | 68,311,461.57 | 67,331,355.24 | 63,202,250.18 | 62,709,554.07 |
| 递延所得税负债 | 46,141,992.89 | 46,153,206.84 | 3,398,939.18 | 3,168,749.8 |
| 非流动负债合计 | 3,610,736,352.49 | 3,966,467,744.46 | 3,002,547,891.92 | 2,781,857,172.81 |
| 负债合计 | 24,141,943,828.3 | 24,413,433,746.63 | 22,876,477,106.26 | 22,507,371,136.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 |
| 资本公积 | 1,608,406,492.69 | 1,601,582,469.23 | 1,601,099,923.38 | 1,601,099,923.38 |
| 其他综合收益 | -8,413,142.82 | -8,413,142.82 | -8,944,829.07 | -7,418,937.88 |
| 盈余公积 | 666,225,375.09 | 666,225,375.09 | 666,225,375.09 | 666,225,375.09 |
| 未分配利润 | 8,260,095,878.53 | 8,218,093,450.95 | 8,263,744,193.01 | 8,080,162,611.12 |
| 归属于母公司股东权益合计 | 12,022,194,351.49 | 11,973,367,900.45 | 12,018,004,410.41 | 11,835,948,719.71 |
| 少数股东权益 | 2,544,395,599.3 | 2,557,831,556.34 | 2,582,776,015.62 | 2,527,649,951.55 |
| 股东权益合计 | 14,566,589,950.79 | 14,531,199,456.79 | 14,600,780,426.03 | 14,363,598,671.26 |
| 负债和股东权益合计 | 38,708,533,779.09 | 38,944,633,203.42 | 37,477,257,532.29 | 36,870,969,807.77 |
| 公告日期 | 2026-10-30 | 2026-08-26 | 2026-04-29 | 2026-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |